Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Updated: Oct 19, 2026
Olivia Brayer's Stock Ratings
Cantor Fitzgerald Analyst
Olivia Brayer is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
2.24%
Smart Score
Overall Average Return Percentile
42nd
Number of Ratings
100
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/21/2026 | CNTB | Buy Now | Connect Biopharma Hldgs | $0.89 | 350.76% | → $4 | Initiates | → Overweight | Get Alert | |
| 03/23/2026 | GOSS | Buy Now | Gossamer Bio | $8.30 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 02/04/2026 | CTMX | Buy Now | CytomX Therapeutics | $2.40 | 316.67% | $6 → $10 | Maintains | Overweight | Get Alert | |
| 12/16/2025 | INSM | Buy Now | Insmed | $95.29 | 141.37% | $216 → $230 | Maintains | Overweight | Get Alert | |
| 12/11/2025 | IKT | Buy Now | Inhibikase Therapeutics | $1.62 | 146.91% | → $4 | Initiates | → Overweight | Get Alert | |
| 10/30/2025 | VNDA | Buy Now | Vanda Pharmaceuticals | $4.14 | 165.7% | $13 → $11 | Maintains | Overweight | Get Alert | |
| 10/08/2025 | VRNA | Buy Now | Verona Pharma PLC ADR | — | — | $100 → $100 | Suspends | Overweight → Overweight | Get Alert | |
| 09/22/2025 | CTMX | Buy Now | CytomX Therapeutics | $2.40 | 150% | → $6 | Initiates | → Overweight | Get Alert | |
| 09/11/2025 | GOSS | Buy Now | Gossamer Bio | $8.30 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 09/10/2025 | UTHR | Buy Now | United Therapeutics | $543.15 | -3.34% | $405 → $525 | Maintains | Overweight | Get Alert | |
| 06/11/2025 | VRNA | Buy Now | Verona Pharma | — | — | $90 → $100 | Maintains | Overweight | Get Alert | |
| 06/02/2025 | UTHR | Buy Now | United Therapeutics | $543.15 | -25.43% | → $405 | Initiates | → Overweight | Get Alert | |
| 05/14/2025 | VNDA | Buy Now | Vanda Pharmaceuticals | $4.14 | 214.01% | → $13 | Assumes | → Overweight | Get Alert | |
| 02/20/2025 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 64.83% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/11/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/04/2025 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -6.48% | $50 → $55 | Maintains | Neutral | Get Alert | |
| 01/31/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 01/24/2025 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/12/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 64.83% | $90 → $90 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/11/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -47.82% | $80 → $80 | Reiterates | Neutral → Neutral | Get Alert | |
| 11/14/2024 | OMER | Buy Now | Omeros | $16.22 | — | — | Reiterates | → Neutral | Get Alert | |
| 11/07/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -47.82% | $70 → $80 | Maintains | Neutral | Get Alert | |
| 11/05/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/30/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 64.83% | $110 → $90 | Maintains | Overweight | Get Alert | |
| 10/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 29.8% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/22/2024 | AMGN | Buy Now | Amgen | $424.94 | -4.69% | $405 → $405 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/18/2024 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -14.99% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/11/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -5.75% | $220 → $220 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/08/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/27/2024 | AMGN | Buy Now | Amgen | $424.94 | -4.69% | → $405 | Initiates | → Overweight | Get Alert | |
| 09/16/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 29.8% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/16/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -54.35% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/16/2024 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -14.99% | $50 → $50 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/16/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $16.49 | -39.36% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 29.8% | $1015 → $1015 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/09/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -54.35% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/09/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 101.46% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $16.49 | -39.36% | $10 → $10 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -5.75% | $220 → $220 | Reiterates | Neutral → Neutral | Get Alert | |
| 08/09/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -54.35% | $70 → $70 | Reiterates | Neutral → Neutral | Get Alert | |
| 08/05/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 101.46% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/02/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $480 → $480 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/22/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -6.28% | $440 → $480 | Maintains | Overweight | Get Alert | |
| 07/22/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 27.88% | $925 → $1000 | Maintains | Neutral | Get Alert | |
| 07/22/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -54.35% | $75 → $70 | Maintains | Neutral | Get Alert | |
| 07/22/2024 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -23.49% | $45 → $45 | Reiterates | Neutral → Neutral | Get Alert | |
| 07/22/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 101.46% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/22/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -5.75% | $150 → $220 | Maintains | Neutral | Get Alert | |
| 07/01/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -35.74% | $150 → $150 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/09/2024 | MNKD | Buy Now | MannKind | $3.09 | 110.36% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/03/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 18.29% | $925 → $925 | Reiterates | Neutral → Neutral | Get Alert | |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 101.46% | $110 → $110 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/17/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 18.29% | → $925 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/15/2024 | MNKD | Buy Now | MannKind | $3.09 | 110.36% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/28/2024 | MNKD | Buy Now | MannKind | $3.09 | 110.36% | $6.5 → $6.5 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/23/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 83.15% | $100 → $100 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/23/2024 | AUPH | Buy Now | Aurinia Pharmaceuticals | $16.49 | -39.36% | $12 → $10 | Maintains | Overweight | Get Alert | |
| 02/23/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -35.74% | $165 → $150 | Maintains | Neutral | Get Alert | |
| 02/20/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -14.09% | $440 → $440 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/20/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/15/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/12/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/07/2024 | GILD | Buy Now | Gilead Sciences | $153.33 | -49.13% | $80 → $78 | Maintains | Neutral | Get Alert | |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -14.09% | $440 → $440 | Reiterates | Overweight → Overweight | Get Alert | |
| 02/06/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 18.29% | $850 → $925 | Maintains | Neutral | Get Alert | |
| 01/24/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -14.09% | $415 → $440 | Maintains | Overweight | Get Alert | |
| 01/22/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 01/18/2024 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 01/12/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -18.97% | $415 → $415 | Reiterates | Overweight → Overweight | Get Alert | |
| 01/09/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -18.97% | $415 → $415 | Reiterates | Overweight → Overweight | Get Alert | |
| 01/09/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $782.00 | 8.7% | $850 → $850 | Reiterates | Neutral → Neutral | Get Alert | |
| 12/14/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -25.8% | $380 → $380 | Reiterates | Overweight → Overweight | Get Alert | |
| 12/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -29.31% | $165 → $165 | Reiterates | Neutral → Neutral | Get Alert | |
| 12/05/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -25.8% | $380 → $380 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/16/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -25.8% | → $380 | Reiterates | Overweight → Overweight | Get Alert | |
| 11/15/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | -6.48% | $68 → $55 | Downgrade | Overweight → Neutral | Get Alert | |
| 11/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -25.8% | $370 → $380 | Maintains | Overweight | Get Alert | |
| 11/02/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 83.15% | $120 → $100 | Maintains | Overweight | Get Alert | |
| 10/16/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 119.78% | → $120 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/16/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -27.75% | → $370 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/16/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -27.17% | $190 → $170 | Maintains | Neutral | Get Alert | |
| 10/09/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 27.52% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/15/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 27.52% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/14/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 119.78% | → $120 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/14/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -18.6% | → $190 | Reiterates | Neutral → Neutral | Get Alert | |
| 09/13/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 119.78% | → $120 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/07/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -27.75% | → $370 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/16/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -18.6% | → $190 | Reiterates | Neutral → Neutral | Get Alert | |
| 08/08/2023 | MNKD | Buy Now | MannKind | $3.09 | 142.72% | $6.5 → $7.5 | Maintains | Overweight | Get Alert | |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -27.75% | $365 → $370 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $54.60 | 119.78% | → $120 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $153.33 | -47.82% | → $80 | Reiterates | Neutral → Neutral | Get Alert | |
| 07/20/2023 | GILD | Buy Now | Gilead Sciences | $153.33 | -47.82% | $85 → $80 | Maintains | Neutral | Get Alert | |
| 07/20/2023 | BMY | Buy Now | Bristol-Myers Squibb | $58.81 | 44.53% | $88 → $85 | Maintains | Overweight | Get Alert | |
| 07/13/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -14.31% | → $200 | Reiterates | Neutral → Neutral | Get Alert | |
| 07/12/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -14.31% | → $200 | Reiterates | Neutral → Neutral | Get Alert | |
| 07/06/2023 | AUPH | Buy Now | Aurinia Pharmaceuticals | $16.49 | -9.04% | → $15 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/23/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $512.14 | -28.73% | $365 → $365 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/23/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -14.31% | $200 → $200 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/22/2023 | ALNY | Buy Now | Alnylam Pharmaceuticals | $233.41 | -14.31% | → $200 | Reiterates | Neutral → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved